Min Tan

Biography

I have a BBiomedSci (Therapeutics) and a BSci with Honours degree from the University of Melbourne. I completed my PhD at the University of Melbourne in 2011, focussing on novel therapies to inhibit pathological fibrosis in the heart and kidney failure. Following my PhD, I received the prestigious Juvenile Diabetes Research Foundation (JDRF) Postdoctoral Fellowship to continue my work in diabetic complications at Baker Heart & Diabetes Institute with a special interest in the role oxidative stress plays in kidney and eye diseases. In 2014, I joined the Glycation, Nutrition and Metabolism Laboratory led by A/Prof Melinda Coughlan at the Baker Heart & Diabetes Institute and in 2016, I was recruited to Monash University's newly established Department of Diabetes at the Central Clinical School. I am a current recipient of a JDRF Advanced Postdoctoral Fellowship to continue my work on finding new therapeutic targets for diabetic complications. I am a member of Australian Diabetes Society and Australian and New Zealand Society of Nephrology. I have a BBiomedSci (Therapeutics) and a BSci with Honours degree from the University of Melbourne. I completed my PhD at the University of Melbourne in 2011, focussing on novel therapies to inhibit pathological fibrosis in the heart and kidney failure. Following my PhD, I received the prestigious Juvenile Diabetes Research Foundation (JDRF) Postdoctoral Fellowship to continue my work in diabetic complications at Baker Heart & Diabetes Institute with a special interest in the role oxidative stress plays in kidney and eye diseases. In 2014, I joined the Glycation, Nutrition and Metabolism Laboratory led by A/Prof Melinda Coughlan at the Baker Heart & Diabetes Institute and in 2016, I was recruited to Monash University's newly established Department of Diabetes at the Central Clinical School. I am a current recipient of a JDRF Advanced Postdoctoral Fellowship to continue my work on finding new therapeutic targets for diabetic complications. I am a member of Australian Diabetes Society and Australian and New Zealand Society of Nephrology.

Research Interest

the role of complement C5a-C5aR1 signalling in diabetic complications inflammation in diabetic kidney disease kidney fibrosis and oxidative stress associated with diabetes novel therapies to treat diabetic complications